The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000329.3(RPE65):c.353+7G>A

CA902539

1117757 (ClinVar)

Gene: RPE65
Condition: RPE65-related recessive retinopathy
Inheritance Mode: Autosomal recessive inheritance
UUID: f90dd243-1bbd-4e2c-93d4-febbf9760216
Approved on: 2024-02-20
Published on: 2024-02-20

HGVS expressions

NM_000329.3:c.353+7G>A
NM_000329.3(RPE65):c.353+7G>A
NC_000001.11:g.68444769C>T
CM000663.2:g.68444769C>T
NC_000001.10:g.68910452C>T
CM000663.1:g.68910452C>T
NC_000001.9:g.68683040C>T
NG_008472.1:g.10191G>A
NG_008472.2:g.10191G>A
ENST00000262340.6:c.353+7G>A
ENST00000262340.5:c.353+7G>A
NM_000329.2:c.353+7G>A

Uncertain Significance

Met criteria codes 1
PM2_Supporting
Not Met criteria codes 2
BP4 PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Leber Congenital Amaurosis/early onset Retinal Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPE65 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Leber Congenital Amaurosis/early onset Retinal Dystrophy VCEP
NM_000329.3(RPE65):c.353+7G>A is a non-coding variant in intron 4 near the junction with exon 4. This variant is present in gnomAD v.2.1.1 at a GrpMax allele frequency of 0.0001415, with 6 alleles / 18394 total alleles in the East Asian population, which is lower than the ClinGen LCA / eoRD VCEP PM2_Supporting threshold of <0.0002 (PM2_Supporting). The splicing impact predictor SpliceAI gives a score of 0.14 for acceptor gain, which is below the ClinGen LCA / eoRD VCEP recommended PP3 threshold of ≥0.2 and higher than the BP4 threshold of <0.1 and does not strongly predict an impact on splicing, so neither in silico predictor code is met. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: PM2_Supporting. (VCEP specifications version 1.0.0; date of approval 09/21/2023).
Met criteria codes
PM2_Supporting
This variant has a frequency in gnomAD of 0.0001415 (East Asian population), which is lower than the VCEP's threshold of <0.0002 for PM2_Supporting.
Not Met criteria codes
BP4
BP4 is not met because the SpliceAI score of 0.14 for acceptor gain is higher than the BP4 threshold of <0.1.
PP3
PP3 is not met because the SpliceAI score of 0.14 for acceptor gain is lower than the PP3 threshold of >0.2.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.